Tema Etfs LLC Cullinan Oncology, Inc. Transaction History
Tema Etfs LLC
- $377 Billion
- Q2 2025
A detailed history of Tema Etfs LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 42,692 shares of CGEM stock, worth $310,370. This represents 0.09% of its overall portfolio holdings.
Number of Shares
42,692
Previous 39,164
9.01%
Holding current value
$310,370
Previous $296 Million
8.43%
% of portfolio
0.09%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding CGEM
# of Institutions
152Shares Held
68.4MCall Options Held
15.6KPut Options Held
17.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$55.6 Million10.72% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$41.8 Million1.91% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$28.1 Million0.74% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$25.8 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$24.8 Million15.23% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $332M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...